Gainers
- Prothena Corporation plc(NASDAQ:PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer's treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative diseases, like Alzheimer's.
- Acumen Pharmaceuticals, Inc.(NASDAQ:ABOS) shares gained 72.1% to $8.09 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
- PepGen Inc. (NASDAQ:PEPG) gained 70% to $8.86 after the company announced results from its Phase 1 healthy...
Login or create a forever free account to read this news
Sign up/Log in